期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (9)
PurposeThe current standard of care for chronic-phase chronic myeloid leukemia (CP-CML) is tyrosine kinase inhibitors (TKIs). Treatment recommendation......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (16)
PurposeResistin, a novel pro-inflammatory protein implicated in inflammatory processes, has been suggested to play a role in colorectal development. H......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (2)
Purpose New therapies are needed for relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma. This phase 1b, open-label trial evaluated two anti-CD20-ba......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (11)
BackgroundIn the phase III TAGS trial, trifluridine/tipiracil showed survival benefit versus placebo in patients with metastatic gastric/gastroesophag......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; ()
PurposeImmune checkpoint inhibitors (ICIs) are increasingly used in the treatment of certain cancers but cause immune-related adverse events (irAEs). ......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (12)
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas technology is a molecular tool specific to sequences for engineering genome......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (14)
IntroductionDiagnosis of cancer in breast cells is an important and vital issue in the field of medicine. In this context, the use of advanced methods......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (13)
PurposeProgrammed death-ligand 1 (PD-L1) and DNA mismatch repair (MMR) are considered predictive biomarkers for immunotherapy in cervical cancer. Howe......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (9)
PurposeRAS mutations are predictors of an adverse outcome in EGFR-targeted therapies and have been proposed as prognostic biomarkers of survival in me......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; ()
PurposePancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors. Endoplasmic reticulum stress (ERS) plays an essential role in PDAC......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (15)
PurposeThis study aimed to investigate the maternal and perinatal outcomes of pregnant patients with CRC using a large population-based database.Metho......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (7)
Purpose A barrier to widespread adoption of chimeric antigen receptor (CAR) T-cell therapy is toxicity. To address this, we recently developed a novel......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (13)
ObjectivesTo compare neoadjuvant chemotherapy (NAC) plus concurrent chemoradiotherapy (CCRT) to CCRT alone in children and adolescents (age & LE; ......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (19)
During eukaryotic gene expression, alternative splicing of messenger RNA precursors is critical in increasing protein diversity and regulatory complex......
期刊: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (9)
PurposeThis study aims to explore the expression of hnRNP K in cervical carcinogenesis and to investigate the regulatory role of hnRNP K on HPV16 onco......